Top Section/Ad
Top Section/Ad
Most recent
M&A could be much needed shot in the arm but dollars expected to dominate
Deal includes $1bn 3.75 year term loan
The German pharmaceutical wholesaler was upgraded to BBB- by S&P last month
US drug company Eli Lilly jolted the dollar market awake on Wednesday with an eight-part jumbo trade to fund two recent acquisitions
More articles/Ad
More articles/Ad
More articles
-
The Finnish biopharmaceutical company tapped shareholders for capital on Thursday night -
The €813m deal is multiple times covered
-
Pharma company wins blowout order book as investors pile in for yield
-
IPO was covered throughout the initial range on day one
-
The medical equipment company is funding its acquisition of Icelandic peer Kerecis with equity
-
The company’s share price dropped after H2 results
